收入和利润（同比环比） - 第三季度销售额为4.63亿美元，同比下降15%，其中产品组合优化举措导致销售额减少5300万美元（10%）[4][5] - 公司2025年第三季度销售额为4.63亿美元，同比下降14.9%（2024年同期为5.44亿美元）[41] - 2025年第三季度净亏损7.42亿美元，而2024年同期净利润为600万美元[41] - 2025年第三季度每股稀释亏损16.21美元，2024年同期为每股盈利0.12美元[41] - 2025年第三季度净亏损7.42亿美元，而2024年同期净利润600万美元[44] - 2025年第三季度调整后营业利润为6500万美元，同比下降25.3%（2024年同期为8700万美元）[52] - 2025年第三季度调整后持续经营业务每股收益为0.78美元，同比下降33.9%（2024年同期为1.18美元）[57] 调整后EBITDA表现 - 调整后EBITDA为1.13亿美元，同比下降19%，其中产品组合优化影响1300万美元（9%）[4][6] - 2025年第三季度调整后EBITDA为1.13亿美元，较2024年同期的1.39亿美元下降19%[45] - 2025年第三季度Life Sciences部门调整后EBITDA为5400万美元，较2024年同期的5900万美元下降8%[45] - 2025年第三季度Specialty Additives部门调整后EBITDA为2600万美元，较2024年同期的3800万美元下降32%[45] 各业务线表现 - 生命科学部门销售额1.62亿美元，同比下降17%，产品组合优化影响3200万美元（16%），调整后EBITDA利润率保持33%[9][11] - 个人护理部门销售额1.47亿美元，同比下降16%，产品组合优化影响1800万美元（10%），调整后EBITDA利润率27.9%[12][13] - 专业添加剂部门销售额1.31亿美元，同比下降13%，产品组合优化影响300万美元（2%）[14][15] - 中间体部门销售额3300万美元，同比下降8%，调整后EBITDA下降22%至700万美元[16][17] - 2025年第三季度Life Sciences部门运营亏损3.43亿美元，而2024年同期盈利4300万美元[41] 现金流和资本支出 - 经营活动现金流为1.14亿美元，同比下降11%[7] - 2025年第三季度经营活动现金流为1.14亿美元，较2024年同期的1.28亿美元下降11%[44] - 2025年第三季度自由现金流为9400万美元，较2024年同期的9900万美元下降5%[49] - 2025年前九个月资本支出为6400万美元，较2024年同期的9900万美元下降35%[44] - 2025年第三季度持续经营自由现金流转化率为96%，高于2024年同期的81%[49] - 2025年第三季度现金及等价物期末余额为2.07亿美元，较期初1.68亿美元增长23%[44] 商誉减值和非经常性项目 - 非现金商誉减值损失7.06亿美元导致持续经营业务亏损7.19亿美元[4][6] - 公司2025年第三季度商誉减值损失达7.06亿美元[41] - 2025年第三季度Goodwill impairment损失达7.06亿美元，主要来自Life Sciences(3.75亿)和Specialty Additives(3.31亿)部门[46] - 2025年前九个月商誉减值损失达7.06亿美元，而2024年同期无此项损失[52][53] - 2025年前九个月Avoca业务减值及出售相关损失为1.75亿美元[52][53] - 2025年第三季度Nutraceuticals业务减值及出售损失为9900万美元（仅2024年发生）[52][53] - 2025年前九个月税前关键项目总额达9.68亿美元，较2024年同期的1.94亿美元增长399%[53] 其他财务数据 - 公司现金及现金等价物从2024年9月的3亿美元降至2025年6月的2.07亿美元[42] - 公司总资产从2024年9月的56.45亿美元降至2025年6月的46.21亿美元[42] - 公司长期债务从2024年9月的13.49亿美元增至2025年6月的13.82亿美元[42] - 2025年第三季度加速折旧费用为2700万美元，较2024年同期的800万美元增长237.5%[52][53] - 2025年第三季度环境准备金调整费用为3000万美元，较2024年同期的3500万美元下降14.3%[52][53] - 2025年第三季度养老金计划重新计量损失为100万美元（仅前九个月发生）[53] - 2025年第三季度未实现证券收益为1900万美元，较2024年同期的100万美元增长1800%[53][57] 管理层讨论和指引 - 公司预计2025财年全年销售额为18.25亿至18.50亿美元，调整后EBITDA为4亿至4.1亿美元[23] - 3000万美元重组计划预计第四季度产生750万美元成本节约[22] - 2025年前九个月自由现金流转换率未达到GAAP标准，公司认为这更能反映实际业务表现[30][39] 公司基本信息 - 公司员工总数约为2,960人，业务覆盖100多个国家[35]

Exhibit 99.1 Press Release For Immediate Release Date: July 29, 2025 GLEN BURNIE BANCORP ANNOUNCES SECOND QUARTER 2025 RESULTS "We are disappointed with our net loss for the quarter. However, we are encouraged by the outcomes of a number of strategic initiatives we started over a year ago. Our strategic priorities continue to focus on increasing new revenue sources by growing our client relationships and becoming more operationally efficient. Achieving these objectives will expand our return on assets and c ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to . Commission file number 001-36859 PayPal Holdings, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 47-2989869 (State or Other Jurisdiction of In ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 1-13792 Global Industrial Company (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organi ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) Commission File Number 1-13455 TETRA Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 74-2148293 (State or Other Jurisdic ...

TETRA TECHNOLOGIES, INC. ANNOUNCES STRONG SECOND QUARTER 2025 RESULTS AND PROVIDES FULL YEAR GUIDANCE Second Quarter 2025 Financial Highlights Exhibit 99.1 THE WOODLANDS, TEXAS, July 29, 2025 / PR Newswire / - TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced second quarter 2025 financial results. Brady Murphy, TETRA President and Chief Executive Officer, stated, "Our employees delivered an exceptional second quarter with Adjusted EBITDA of $35.9 million, adjusted EBITDA margins of 20 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36691 Booking Holdings Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Huntington Bancshares Incorporated (Exact name of registrant as specified in its charter) Maryland 1-34073 31-0724920 (State or other jurisdiction of incorporation or or ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Huntington Bancshares Incorporated (Exact name of registrant as specified in its charter) Maryland 1-34073 31-0724920 (State or other jurisdiction of incorporation or or ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-11884 ROYAL CARIBBEAN CRUISES LTD. (Exact name of registrant as specified in its charter) Republic of Liberia 98 ...